Frances M Richards
7PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 19, 2022
Size-tuneable and immunocompatible polymer nanocarriers for drug delivery in pancreatic cancer.Andrea Bistrović Popov, Francesca Melle, Emily Linnane
|Mar 29, 2022
Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment.Marina Roy-Luzarraga, Louise E Reynolds, Beatriz de Luxán-Delgado
|Aug 11, 2021
T Cell-Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Cancer.Dandan Li, Nicholas Schaub, Theresa M Guerin
|Oct 31, 2020
CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response.Daniele Biasci, Martin Smoragiewicz, Claire M Connell
|Nov 16, 2019
Targeting melanoma's MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors.Matthew J Sale, Emma Minihane, Noel R Monks
|Jun 13, 2018
The ATR Inhibitor AZD6738 Synergizes with Gemcitabine <i>In Vitro</i> and <i>In Vivo</i> to Induce Pancreatic Ductal Adenocarcinoma Regression.Yann Wallez, Charles R Dunlop, Timothy Isaac Johnson
Pageof 2
Frequent Collaborators
2 joint publications
Siang-Boon Koh
2 joint publications
Charles R Dunlop
2 joint publications
Duncan I Jodrell
1 joint publications
Yann Wallez
1 joint publications
Courtney L Andersen
1 joint publications
Paul D Smith
1 joint publications
Simon J Cook
1 joint publications
Martin Smoragiewicz
1 joint publications
Claire M Connell
1 joint publications
Zhikai Wang
